The Research & Development team at Cygnal Therapeutics is responsible for pioneering advancements in exoneural biology by designing and conducting innovative experiments to discover and develop novel therapeutics. Comprising experienced directors and scientific leaders, the team focuses on translating cutting-edge biological insights into transformative drug candidates, driving the company’s mission to revolutionize treatment options in this emerging field.
View all